Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo

Daniel Sommermeyer, Michael Hudecek, Paula L. Kosasih, Tea Gogishvili, David G. Maloney, Cameron J. Turtle, Stanley R. Riddell

Leukemia · 2015 · 861 citations · 236 references

Concepts

References

236